MetLife, Inc.
MET Financial Services · Insurance - LifeFairly valued.
Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.
What the filing actually says.
MetLife, Inc.’s 2026 10-Q, filed May 7, 2026, dedicates a portion of its Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A — management’s narrative on financial performance) to detailing market risk exposures. The company explicitly states it “regularly analyze[s] our exposure to interest rate, equity market price and foreign currency exchange rate risks.” This analysis has led to a determination that the “estimated fair values of certain assets and liabilities are materially exposed” to fluctuations in these market variables, a critical observation for an insurer whose business model is inherently sensitive to such movements.
This reading, however, lacks the quantitative forensic tools often employed for a deeper dive. The Beneish M-Score, Beneish’s 1999 eight-ratio earnings-manipulation detector, is not available. Similarly, Altman’s Z″, Altman’s 1968 bankruptcy-distress index, and Piotroski’s F-Score, Piotroski’s 2000 nine-point fundamental strength scan, are absent. The Fog Index, a readability score where 12 equals newspaper clarity and 18+ suggests obfuscation, is also not provided. The absence of these metrics limits a quantitative assessment of potential accounting anomalies or fundamental strength.
Item 7, the MD&A, highlights that MetLife has exposure to such market risks through our insurance operations and investment activities. This is a crucial disclosure for an insurer, as its business inherently involves managing large investment portfolios and long-term liabilities sensitive to these market movements. The company states it uses a “variety of strategies to manage these risks, including the use of derivatives,” referencing its 2025 Annual Report for further details on its risk management framework.
While the filing clearly articulates the existence of significant market risks and the intent to manage them, the provided excerpts do not offer a granular view of the current magnitude of these exposures or the specific effectiveness of the derivative strategies employed. The “Note Regarding Forward-Looking Statements” in Item 1A also reminds readers that expectations or forecasts of future events are not guarantees. Without the quantitative forensic scores, this reading cannot offer a data-driven assessment of potential financial distress or earnings manipulation. It describes the company’s acknowledged risk landscape, not its current financial health in detail.
Filing timeline
- May 7, 202610-QQuarterly report (2026-03-31)Period: 2026-03-310Read →
- May 6, 20268-KMaterial event (2026-05-06)### Item 2.02 Results of Operations and Financial Condition . On May 6, 2025, MetLife, Inc. issued (i) a news release announcing its results for the quarter end0Read →
- Apr 29, 2026DEF 14AProxy statement (2026-06-16)0Read →
- Apr 7, 20268-KMaterial event (2026-04-07)### Item 7.01 Regulation FD Disclosure . MetLife, Inc. (the "Company") is furnishing this Current Report on Form 8-K to disclose preliminary information regardi0Read →
- Mar 5, 20268-KMaterial event (2026-03-05)### Item 8.01 Other Events . On March 5, 2026, MetLife, Inc. issued a news release confirming its previously announced declaration of a first quarter 2026 divid0Read →
- Feb 19, 202610-KAnnual report (2025-12-31)Period: 2025-12-310Read →
If this case caught your eye
Financial Shenanigans
Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.
View on Amazon →The Interpretation of Financial Statements
The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.
View on Amazon →Quality of Earnings
Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.
View on Amazon →